文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

目前对表观遗传学在黑色素瘤治疗及耐药性中的作用的理解。

Current understanding of epigenetics role in melanoma treatment and resistance.

作者信息

Karami Fath Mohsen, Azargoonjahromi Ali, Soofi Asma, Almasi Faezeh, Hosseinzadeh Shahnaz, Khalili Saeed, Sheikhi Kamran, Ferdousmakan Saeid, Owrangi Soroor, Fahimi Minoovash, Zalpoor Hamidreza, Nabi Afjadi Mohsen, Payandeh Zahra, Pourzardosht Navid

机构信息

Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Cancer Cell Int. 2022 Oct 12;22(1):313. doi: 10.1186/s12935-022-02738-0.


DOI:10.1186/s12935-022-02738-0
PMID:36224606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9555085/
Abstract

Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in melanocytes. Several factors have been considered to be involved in melanoma progression, including genetic alteration, processes of damaged DNA repair, and changes in mechanisms of cell growth and proliferation. Epigenetics is the other factor with a crucial role in melanoma development. Epigenetic changes have become novel targets for treating patients suffering from melanoma. These changes can alter the expression of microRNAs and their interaction with target genes, which involves cell growth, differentiation, or even death. Given these circumstances, we conducted the present review to discuss the melanoma risk factors and represent the current knowledge about the factors related to its etiopathogenesis. Moreover, various epigenetic pathways, which are involved in melanoma progression, treatment, and chemo-resistance, as well as employed epigenetic factors as a solution to the problems, will be discussed in detail.

摘要

黑色素瘤是由黑素细胞基因突变导致的最具侵袭性的皮肤癌形式。几个因素被认为与黑色素瘤进展有关,包括基因改变、受损DNA修复过程以及细胞生长和增殖机制的变化。表观遗传学是在黑色素瘤发展中起关键作用的另一个因素。表观遗传变化已成为治疗黑色素瘤患者的新靶点。这些变化可改变微小RNA的表达及其与靶基因的相互作用,这涉及细胞生长、分化甚至死亡。鉴于这些情况,我们进行了本综述,以讨论黑色素瘤的危险因素,并介绍有关其发病机制相关因素的当前知识。此外,将详细讨论参与黑色素瘤进展、治疗和化疗耐药性的各种表观遗传途径,以及作为解决问题手段所采用的表观遗传因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/e4c02e61ecc5/12935_2022_2738_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/b4bf0948b2ee/12935_2022_2738_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/ee0b61c17c8e/12935_2022_2738_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/e4c02e61ecc5/12935_2022_2738_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/b4bf0948b2ee/12935_2022_2738_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/ee0b61c17c8e/12935_2022_2738_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e41/9555085/e4c02e61ecc5/12935_2022_2738_Fig3_HTML.jpg

相似文献

[1]
Current understanding of epigenetics role in melanoma treatment and resistance.

Cancer Cell Int. 2022-10-12

[2]
Epigenetics in human melanoma.

Cancer Control. 2009-7

[3]
Epigenetics of melanoma: implications for immune-based therapies.

Immunotherapy. 2013-10

[4]
Melanoma epigenetics: novel mechanisms, markers, and medicines.

Lab Invest. 2014-6-30

[5]
Epigenetics and cutaneous neoplasms: from mechanism to therapy.

Epigenomics. 2023-2

[6]
The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies".

Theranostics. 2020

[7]
Update on melanoma epigenetics.

Curr Opin Oncol. 2015-9

[8]
MicroRNA in Melanoma.

Ochsner J. 2010

[9]
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies.

Cancers (Basel). 2022-11-28

[10]
Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer.

Adv Exp Med Biol. 2008

引用本文的文献

[1]
Circular RNA circ_0001591 Contributes to Melanoma Cell Migration Through AXL and FRA1 Proteins by Targeting miR-20a-3p and miR-34a-5p.

Genes (Basel). 2025-7-30

[2]
Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary Study.

Cancers (Basel). 2025-7-10

[3]
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View.

Pharmaceuticals (Basel). 2025-6-6

[4]
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.

Transl Oncol. 2025-6-23

[5]
DNA hypermethylation of tumor suppressor genes among oral squamous cell carcinoma patients: a prominent diagnostic biomarker.

Mol Biol Rep. 2024-12-7

[6]
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer.

Pigment Cell Melanoma Res. 2025-1

[7]
Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAF-Induced Cellular Senescence in Human Melanocytes.

J Invest Dermatol. 2024-11-23

[8]
Utilizing PRAME Expression and a Meta-Analytic Framework for iSALT to Explore Atypical Late-Onset Nevi of the Elderly and Their Relationship With Lentiginous and Nested Nevoid Melanomas.

Am J Dermatopathol. 2024-12-1

[9]
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.

Cancers (Basel). 2024-8-16

[10]
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications.

Heliyon. 2024-8-2

本文引用的文献

[1]
Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance.

J Natl Cancer Cent. 2021-1-16

[2]
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways.

Inflammopharmacology. 2022-10

[3]
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors.

Cell Mol Biol Lett. 2022-7-22

[4]
Possible role of autophagy induced by COVID-19 in cancer progression, chemo-resistance, and tumor recurrence.

Infect Agent Cancer. 2022-7-18

[5]
Hypoxia-inducible factor 1 alpha (HIF-1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy.

Hum Cell. 2022-9

[6]
The role of epigenetic modifications in drug resistance and treatment of breast cancer.

Cell Mol Biol Lett. 2022-6-28

[7]
Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality.

Hum Cell. 2022-7

[8]
Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.

Cancer Cell Int. 2022-5-25

[9]
Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target.

Nat Chem Biol. 2022-8

[10]
Anti-cancer peptide-based therapeutic strategies in solid tumors.

Cell Mol Biol Lett. 2022-4-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索